China Medicine Corporation (CHME)
OTCMKTS
· Delayed Price · Currency is USD
0.0350
+0.0025 (7.69%)
At close: Jan 6, 2026
China Medicine Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2009 | FY 2008 | FY 2007 | FY 2006 | FY 2005 | 2004 - 2003 |
|---|---|---|---|---|---|---|---|
Period Ending | Jan '26 Jan 5, 2026 | Dec '09 Dec 31, 2009 | Dec '08 Dec 31, 2008 | Dec '07 Dec 31, 2007 | Dec '06 Dec 31, 2006 | Dec '05 Dec 31, 2005 | 2004 - 2003 |
| Market Capitalization | 1 | 66 | 11 | 42 | 23 | - | Upgrade
|
| Market Cap Growth | 75.00% | 500.88% | -74.05% | 87.05% | - | - | Upgrade
|
| Enterprise Value | - | 67 | 9 | 39 | 21 | - | Upgrade
|
| Last Close Price | 0.04 | 4.30 | 0.72 | 2.85 | 3.06 | - | Upgrade
|
| PE Ratio | - | 38.35 | 1.20 | 6.14 | 4.72 | - | Upgrade
|
| PS Ratio | 0.01 | 1.02 | 0.20 | 1.00 | 0.94 | - | Upgrade
|
| PB Ratio | 0.01 | 1.45 | 0.25 | 1.33 | 1.59 | - | Upgrade
|
| P/TBV Ratio | 0.01 | 2.33 | 0.26 | 1.42 | 1.72 | - | Upgrade
|
| P/FCF Ratio | 0.13 | 4.87 | 7.11 | - | - | - | Upgrade
|
| P/OCF Ratio | 0.08 | 3.88 | 2.61 | - | - | - | Upgrade
|
| EV/Sales Ratio | - | 1.04 | 0.17 | 0.93 | 0.88 | - | Upgrade
|
| EV/EBITDA Ratio | - | 5.06 | 0.80 | 4.47 | 2.91 | - | Upgrade
|
| EV/EBIT Ratio | - | 5.48 | 0.84 | 4.64 | 2.97 | - | Upgrade
|
| EV/FCF Ratio | - | 4.97 | 5.91 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.03 | 0.21 | - | - | - | 0.02 | Upgrade
|
| Debt / EBITDA Ratio | 0.30 | 0.72 | - | - | - | 0.02 | Upgrade
|
| Debt / FCF Ratio | 0.63 | 0.70 | - | - | - | 0.10 | Upgrade
|
| Net Debt / Equity Ratio | -0.03 | 0.20 | -0.06 | -0.18 | -0.03 | 0.00 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.28 | 0.68 | -0.25 | -0.66 | -0.05 | 0.00 | Upgrade
|
| Net Debt / FCF Ratio | -0.59 | 0.67 | -1.81 | 2.14 | 0.12 | 0.00 | Upgrade
|
| Asset Turnover | 0.70 | 1.16 | 1.39 | 1.78 | 2.39 | 3.44 | Upgrade
|
| Inventory Turnover | 6.33 | 12.28 | 8.78 | 10.16 | 9.15 | 8.07 | Upgrade
|
| Quick Ratio | 2.97 | 1.58 | 20.40 | 22.48 | 12.34 | 4.38 | Upgrade
|
| Current Ratio | 11.15 | 2.10 | 31.18 | 34.09 | 20.79 | 8.76 | Upgrade
|
| Return on Equity (ROE) | 6.63% | 3.15% | 23.90% | 29.52% | 50.23% | 166.44% | Upgrade
|
| Return on Assets (ROA) | 7.82% | 13.75% | 17.67% | 22.18% | 44.25% | 75.94% | Upgrade
|
| Return on Invested Capital (ROIC) | 5.87% | 6.63% | 26.75% | 34.00% | 60.91% | 157.75% | Upgrade
|
| Return on Capital Employed (ROCE) | 9.30% | 23.40% | 25.10% | 26.50% | 50.20% | 110.90% | Upgrade
|
| Earnings Yield | -13.54% | 2.61% | 83.24% | 16.28% | 21.20% | - | Upgrade
|
| FCF Yield | 768.28% | 20.52% | 14.07% | -6.39% | -13.48% | - | Upgrade
|
| Buyback Yield / Dilution | -107.86% | -0.67% | -12.08% | -78.45% | -17.21% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.